Cargando…
Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability
Acute myocardial infarction dominates coronary artery disease mortality. Identifying bio-signatures for plaque destabilization and rupture is important for preventing the transition from coronary stability to instability and the occurrence of thrombosis events. This computational systems biology stu...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470306/ https://www.ncbi.nlm.nih.gov/pubmed/37664595 http://dx.doi.org/10.1016/j.isci.2023.107587 |
_version_ | 1785099653371396096 |
---|---|
author | Zhang, Ge Cui, Xiaolin Qin, Zhen Wang, Zeyu Lu, Yongzheng Xu, Yanyan Xu, Shuai Tang, Laiyi Zhang, Li Liu, Gangqiong Wang, Xiaofang Zhang, Jinying Tang, Junnan |
author_facet | Zhang, Ge Cui, Xiaolin Qin, Zhen Wang, Zeyu Lu, Yongzheng Xu, Yanyan Xu, Shuai Tang, Laiyi Zhang, Li Liu, Gangqiong Wang, Xiaofang Zhang, Jinying Tang, Junnan |
author_sort | Zhang, Ge |
collection | PubMed |
description | Acute myocardial infarction dominates coronary artery disease mortality. Identifying bio-signatures for plaque destabilization and rupture is important for preventing the transition from coronary stability to instability and the occurrence of thrombosis events. This computational systems biology study enrolled 2,235 samples from 22 independent bulks cohorts and 14 samples from two single-cell cohorts. A machine-learning integrative program containing nine learners was developed to generate a warning classifier linked to atherosclerotic plaque vulnerability signature (APVS). The classifier displays the reliable performance and robustness for distinguishing ST-elevation myocardial infarction from chronic coronary syndrome at presentation, and revealed higher accuracy to 33 pathogenic biomarkers. We also developed an APVS-based quantification system (APVSLevel) for comprehensively quantifying atherosclerotic plaque vulnerability, empowering early-warning capabilities, and accurate assessment of atherosclerosis severity. It unraveled the multidimensional dysregulated mechanisms at high resolution. This study provides a potential tool for macro-level differential diagnosis and evaluation of subtle genetic pathological changes in atherosclerosis. |
format | Online Article Text |
id | pubmed-10470306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104703062023-09-01 Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability Zhang, Ge Cui, Xiaolin Qin, Zhen Wang, Zeyu Lu, Yongzheng Xu, Yanyan Xu, Shuai Tang, Laiyi Zhang, Li Liu, Gangqiong Wang, Xiaofang Zhang, Jinying Tang, Junnan iScience Article Acute myocardial infarction dominates coronary artery disease mortality. Identifying bio-signatures for plaque destabilization and rupture is important for preventing the transition from coronary stability to instability and the occurrence of thrombosis events. This computational systems biology study enrolled 2,235 samples from 22 independent bulks cohorts and 14 samples from two single-cell cohorts. A machine-learning integrative program containing nine learners was developed to generate a warning classifier linked to atherosclerotic plaque vulnerability signature (APVS). The classifier displays the reliable performance and robustness for distinguishing ST-elevation myocardial infarction from chronic coronary syndrome at presentation, and revealed higher accuracy to 33 pathogenic biomarkers. We also developed an APVS-based quantification system (APVSLevel) for comprehensively quantifying atherosclerotic plaque vulnerability, empowering early-warning capabilities, and accurate assessment of atherosclerosis severity. It unraveled the multidimensional dysregulated mechanisms at high resolution. This study provides a potential tool for macro-level differential diagnosis and evaluation of subtle genetic pathological changes in atherosclerosis. Elsevier 2023-08-09 /pmc/articles/PMC10470306/ /pubmed/37664595 http://dx.doi.org/10.1016/j.isci.2023.107587 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Zhang, Ge Cui, Xiaolin Qin, Zhen Wang, Zeyu Lu, Yongzheng Xu, Yanyan Xu, Shuai Tang, Laiyi Zhang, Li Liu, Gangqiong Wang, Xiaofang Zhang, Jinying Tang, Junnan Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability |
title | Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability |
title_full | Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability |
title_fullStr | Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability |
title_full_unstemmed | Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability |
title_short | Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability |
title_sort | atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470306/ https://www.ncbi.nlm.nih.gov/pubmed/37664595 http://dx.doi.org/10.1016/j.isci.2023.107587 |
work_keys_str_mv | AT zhangge atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT cuixiaolin atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT qinzhen atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT wangzeyu atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT luyongzheng atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT xuyanyan atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT xushuai atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT tanglaiyi atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT zhangli atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT liugangqiong atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT wangxiaofang atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT zhangjinying atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability AT tangjunnan atheroscleroticplaquevulnerabilityquantificationsystemforclinicalandbiologicalinterpretability |